Adult height and cryptogenic fibrosing alveolitis: A case-control study using the UK General Practice Research Database

Thorax

Volumn 55, Issue 10, 2000, Pages 864-866

  Hubbard, Richard ^a   Venn, Andrea ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Adult height; Cryptogenic fibrosing alveolitis; Early life experience; UK General Practice Research Database

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; BODY HEIGHT; CASE CONTROL STUDY; CIGARETTE SMOKING; ENVIRONMENTAL EXPOSURE; FEMALE; FIBROSING ALVEOLITIS; HUMAN; MALE; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; UNITED KINGDOM;

AGED; BODY HEIGHT; BODY MASS INDEX; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; GLUCOCORTICOIDS; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PULMONARY FIBROSIS; RISK FACTORS; SMOKING;

EID: 0033802663     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.55.10.864     Document Type: Article

References (20)

1. 1 Hubbard R, Johnston I, Coultas DB, et al. Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax 1996;51:711-6.
2. 2 Johnston I, Britton J, Kinnear W, et al. Rising mortality from cryptogenic fibrosing alveolitis. BMJ 1990;301:1017-21.
3. 3 Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ 1990;301:1015-7.
4. 4 Hubbard R, Lewis S, Richards K, et al. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996;347:284-9.
5. 5 Iwai K, Mori T, Yamada N, et al. Idiopathic pulmonary fibrosis. Epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 1991;150:670-5.
6. 6 Baumgartner KB, Samet JM, Coultas DB, et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: A multicenter case-control study. Am J Epidemiol 1997;45:S61.
7. 7 Baumgartner KB, Samet JM, Stidly CA, et al. Cigarette smoking: A risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997;155:242-8.
8. 8 Hubbard R, Venn A, Smith C, et al. Exposure to commonly prescribed drugs and the aetiology of cryptogenic fibrosing alveolitis: a case-control study. Am J Respir Crit Care Med 1998;157:743-7.
9. 9 Leon DA, Ben-Shlomo Y. Pre-adult influences on cardiovascular disease and cancer. In: Kuh D, Ben-Shlomo Y, eds. A life course approach to chronic disease epidemiology. Oxford: Oxford University Press, 1997: 45-77.
10. 10 Leon DA, Davey Smith G, Shipley M, et al. Adult height and mortality in London: early life, socioeconomic confounding or shrinkage? J Epidemiol Community Health 1995;49:5 9.
11. 11 Hubbard R, Venn A, Lewis S, et al. Lung cancer and cryptogenic fibrosing alveolitis: a population based cohort study. Am J Respir Crit Care Med 2000;161:5-8.
12. 12 Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997;350:1097-9.
13. 13 Jenkins SC, Moxham J. The effects of mild obesity on lung function. Respir Med 1991;85:309-11.
14. 14 Shaheen SO, Sterne JAC, Montgomery SM, et al. Body weight, body mass index and asthma in young adults. Thorax 1999;54:396-402.
15. 15 Office for National Statistics. Living in Britain: preliminary results from the 1996 General Household Survey. D2 24. London: The Stationery Office, 1997: 16-7.
16. 16 Yarnell JWG, Limb ES, Layzell JM, et al. Height: a risk factor for ischaemic heart disease: prospective results from the Caerphilly and Speedwell heart disease studies. Eur Heart J 1992;13:1602-5.
17. 17 Palmer JR, Rosenberg L, Shapiro S. Stature and the risk of myocardial infarction in women. Am J Epidemiol 1990;132: 27-32.
18. 18 Kuh D, Power C, Blane D, et al. Social pathways between childhood and adult health. In Kuh D, Ben-Shlomo Y, eds. A life course approach to chronic disease epidemiology. Oxford: Oxford Medical Publications, 1997:169-98.
19. 19 Jeffery PK. The development of large and small airways. Am J Respir Crit Care Med 1998;157:S174-80.
20. 20 Becklake MR, Toyota B, Stewart M, et al Lung structure as a risk factor in adverse pulmonary responses to asbestos exposure. Am Rev Respir Dis 1983;128:385-8.